Recombinant Human OTOR #abs01268

abs01268-5ug

1-2 Weeks

138

abs01268-20ug

1-2 Weeks

344

abs01268-1mg

1-2 Weeks

5058

Species

Human

Source

Escherichia coli.

Format

After concentration and filtration through a 0.2 μm filter, the solution was lyophilized. The original solution was in 20 mM PB at pH 7.4 and contained 150mM NaCl. To generate similar content, the information provided in the original text has been rearranged.

Properties

aa_sequence

GYFPRNLVKE VHGIFMDRLA VPTTDIDFFC VYTISLASAQ SKKLCADDEC EDYNAPDCRF INVKKGQQIY VYSKLVKENG AGEFWAGSVY GDGQDEMGVV QRVYQEATKE
QRSKLVKENG EDYNAPDCRF VHGIFMDRLA SKKLCADDEC GYFPRNLVKE VPTTDIDFFC VYTISLASAQ INVKKGQQIY AGEFWAGSVY VYSKLVKENG GDGQDEMGVV QRVYQEATKE

Concentration

> 97 % by SDS-PAGE and HPLC analyses

Endotoxin_level

The LAL method determined that the Recombinant HumanOTOR contains less than 1 EU/μg.

Reconstitution

It is recommended to briefly centrifuge the vial before opening to ensure the contents settle at the bottom. Reconstitution should be done using sterile distilled water or a buffered solution with 0.1% BSA to achieve a concentration of 0.1-1.0 mg/mL. Stock solutions are to be divided into working aliquots and stored at temperatures of -20°C or below. Dilutions can be made using appropriate buffered solutions. It is important to ensure that the generated content closely follows the original text information.

Stability & Storage

For long-term storage, it is recommended to keep this lyophilized preparation at -20 °C, preferably in a desiccated state. However, it can be stored at 2-8 °C and remains stable. Once reconstituted, the preparation maintains stability for one week at 2-8 °C. To ensure maximum stability, it is advised to divide the reconstituted preparation into working aliquots and store them at temperatures ranging from -20 °C to -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles.

References

References

1. Robertson NG, Heller S, Lin JS, et al. 2000. Genomics, 66: 242-8.